Eric Jia-Sobota, Founder, Author at EverGlade Consulting - Page 4 of 8

Eric Jia-Sobota, Founder

Eric Jia-Sobota is the National Leader of EverGlade’s Consulting Practice and the Founder of the Company. Eric’s consulting experience spans almost two decades across a breadth of industries, including, Federal Contracting, Life Sciences, Nonprofit, Technology, Construction, Healthcare, and others. View Eric's resume at https://ericjia-sobota.com/

Eric Jia-Sobota
A closeup shot of a scientist conducting the gel electrophoresis biological process as part of coronavirus research

BARDA Announces Request for Project Proposals for Small Molecule Drugs

Leave a Comment / All Posts, BARDA, Life Sciences / By

BARDA RRPV 24-03-SmMol The Biomedical Advanced Research and Development Authority (BARDA) has released a Request for Project Proposals (RPP) under the Rapid Response Partnership Vehicle (RRPV) for developing small molecule therapeutics aimed at COVID-19 Pre-exposure Prophylaxis (PrEP). This initiative enhances national health security by advancing medical countermeasures against SARS-CoV-2 and future health threats. BARDA’s call […]

BARDA Announces Request for Project Proposals for Small Molecule Drugs Read More »

Filovirus Monoclonal Antibodies

BARDA Announces RPP for Manufacturing Optimization for Filovirus Monoclonal Antibodies

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has issued a Request for Project Proposals (RPP) for “Manufacturing Optimization for Filovirus Monoclonal Antibodies.” The RPP was released on June 24, 2024, with proposals due by July 22, 2024. This initiative aims to enhance the manufacturing development of monoclonal antibody (mAb) cocktails targeting filoviruses like Ebola and Marburg viruses.

BARDA Announces RPP for Manufacturing Optimization for Filovirus Monoclonal Antibodies Read More »

African American woman in a technically advanced career

ARPA-H Announces Small Business Opportunities

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA-H) has announced an upcoming solicitation for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) contracts for FY2024. The initiative targets innovative firms capable of conducting cutting-edge research and development, with a focus on commercializing the results. The solicitation includes opportunities for Phase I, Direct to Phase II, and Fast Track contracts.

ARPA-H Announces Small Business Opportunities Read More »

Abstract virus on blue background

BARDA Announces Request for Project Proposal to Establish Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services

Leave a Comment / All Posts, BARDA, Life Sciences / By

Biomedical Advanced Research and Development Authority (BARDA) through the Rapid Response Partnership Vehicle (RRPV) initiative released a Request for Project Proposals (RPP) to establish Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services to support vaccine development and response to pandemics and emerging infectious diseases.

BARDA Announces Request for Project Proposal to Establish Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services Read More »

Futuristic doctor with augmented reality tablet

A Comprehensive Guide to ARPA-H Funding: Process, Financial, and Technical Requirements

Leave a Comment / All Posts, ARPA-H, Guides, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA-H) stands as a beacon for those within the biomedical and health sectors, propelling transformative research initiatives and breakthroughs. The pursuit of funding from ARPA-H is a monumental stride for entities operating in these domains. This guide endeavors to navigate you through the intricate application process, the financial prerequisites, and the technical stipulations pivotal for securing ARPA-H funding

A Comprehensive Guide to ARPA-H Funding: Process, Financial, and Technical Requirements Read More »

Covid Research

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding

Leave a Comment / All Posts, BARDA, Life Sciences / By

EverGlade Consulting, a national consulting firm, has helped ModeX Therapeutics successfully secure up to $168 million in funding through a contract with the Biomedical Advanced Research and Development Authority (“BARDA”) to develop novel multispecific antibodies against viral infectious disease threats. How Funding Will Be Used The $168 million in BARDA funding will advance research and clinical trials for multispecific

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding Read More »

Wearable medical device

ARPA-H Solicits Proposals For REACT Program

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Advanced Research Projects Agency (ARPA-H) Solicits Proposals for Resilient Extended Automatic Cell Therapies (REACT) Program The Advanced Research Projects Agency for Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies (REACT) program, employing a Master Announcement Instruction (MAI) strategy for proposal submissions. This strategy enables proposers to tailor their submissions

ARPA-H Solicits Proposals For REACT Program Read More »

BARDA Post-Award represented with a digital drawing of virus and microscope

Effective Post-Award Management of a BARDA Contract

Leave a Comment / All Posts, BARDA, Guides, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) plays a pivotal role in the United States’ preparedness for public health emergencies. BARDA contracts support the development, procurement, and deployment of medical countermeasures critical for safeguarding public health during crises. Once awarded a BARDA contract, effective post-award management becomes paramount to ensure the successful execution of

Effective Post-Award Management of a BARDA Contract Read More »

medical countermeasures development

Guide to BARDA Funding Broad Agency Announcement Update

Leave a Comment / All Posts, BARDA, Guides, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), a USG agency that operates within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has recently released a new, modernized Broad Agency Announcement (BAA) with the goal of enhancing efficiency, improving responsiveness, and reducing

Guide to BARDA Funding Broad Agency Announcement Update Read More »

Female scientist in a hazmat suit researching WMD-related security challenges

DTRA BAA Weapons of Mass Destruction Amendment

Leave a Comment / All Posts, DTRA, Life Sciences / By

DTRA BAA Outlines New Opportunity to Identify and Counter Weapons of Mass Destruction (WMD) through the Strategic Trends Research Initiative The Defense Threat Reduction Agency (DTRA) has amended its Broad Agency Announcement (BAA) to offer new funding opportunities through the Strategic Trends Research Initiative (STRI) for identifying and countering Weapons of Mass Destruction (WMD), defined

DTRA BAA Weapons of Mass Destruction Amendment Read More »

CHIPS Act Funding Alert

CHIPS Act Pre-Funding Alert

Leave a Comment / CHIPS, Emerging Technologies / By

CHIPS Act Program Begins Accepting Pre-Applications for Large Supply Chain Projects In a move to secure America’s leadership in the semiconductor sector, the U.S. Department of Commerce (DoC) announced on Friday, the start of its rolling pre-application process for large-scale supply chain projects and wafer manufacturing facilities. The projects that qualify must have capital investments

CHIPS Act Pre-Funding Alert Read More »

JPEO Funding - military man with gas mask and rifle

A Guide to JPEO Funding

Leave a Comment / All Posts, Guides, JPEO, Life Sciences / By

A Guide to JPEO Funding: Application Process, Financial and Technical Requirements In the complex ecosystem of defense and homeland security, the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) holds a distinct role. This specialized office under the Department of Defense (DoD) focuses on safeguarding the United States military and its

A Guide to JPEO Funding Read More »

Scroll to Top